 |
 |
 |
||
|
||||
 |
|
| Updated Feb. 8, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
|
|
|
Hospitals Hone Their Medication Reconciliation Skills Studies at ASHP document improved safety, cost savings and the potential for better Joint Commission compliance ISSUE: JANUARY, 2010 Implementing medication reconciliation has proven a challenge for many hospitals, but those that have opted to do so have found that their decisions can pay off in fewer medication errors and less risk for adverse events for patients. read more |
|
|
Antibiotic Therapy Outcomes Boosted by Stewardship Plans ISSUE: JANUARY, 2010 Las Vegas—Inappropriate antibiotic use fell sharply and pharmacy costs were reduced at several hospitals after the launch of pharmacist-managed antimicrobial stewardship programs, according to studies presented at the American Society of Health-System Pharmacists’ (ASHP) Midyear Clinical Meeting in December 2009. read more |
|
|
More Proof Pharmacy Profession Enhances Care, But at a Savings? ISSUE: JANUARY, 2010 Perhaps you thought it had already been proved: including a clinical pharmacist at an outpatient clinic to assure optimal therapy for blood pressure (BP) management significantly improves patients’ chances for reaching goals. But that finding, previously reached by small, single-site studies of varying designs, has now been confirmed in a large, well-designed, multisite study published in the Archives of Internal Medicine (2009;169:1996-2002). read more |
|
|
Trastuzumab, Lapatinib Land One-Two Punch In Resistant Breast Cancer ISSUE: JANUARY, 2010 San Antonio—The combination therapy of trastuzumab (Herceptin, Genentech) and lapatinib (Tykerb, GlaxoSmithKline) improves overall survival by 20 weeks compared with lapatinib alone in women with HER2-positive metastatic breast cancer (MBC) who have progressed on therapy with trastuzumab. Survival was roughly 60 weeks in the combination arm and 40 weeks in the lapatinib-only arm, according to study results reported at the recent San Antonio Breast Cancer Symposium. read more |
|
|
4
|
||||||
| home | about us | advertise | contact | publications |